43 MET immunoreactivity and poor prognosis Table 1: Properties of the purchased MET antibodies. Clone Catalog# Company Species Clonality Isotype Reactivity Antigen region Immunogen Peptide length and amino acid mapping region D1C2 8198 Cell Signaling Technology® Rabbit Mono IgG Human C-terminus of Human MET Peptide Mapping to residues near the C-terminus of Human MET. Peptide length, specific amino acid region & MET isoform are proprietary information. SP44* M3440 Spring™ Bioscience Rabbit Mono IgG Human C-terminus of Human MET Peptide Mapping to residues near the C-terminus of Human MET. Peptide length, specific amino acid region & MET isoform are proprietary information. CVD13* 71-8000 Invitrogen™ Rabbit Poly IgG Human C-terminus of Human MET Peptide Mapping within the last 30 C-terminal amino acids of Human MET (Accession: NP_001120972.1). Peptide length is proprietary information. C-12 Sc-10 Santa Cruz Biotechnology, Inc. Rabbit Poly IgG Human C-terminus of Human MET Peptide 15-25 amino acid long peptide mapping within the last 50 C-terminal amino acids of Human MET (Accession: NP_000236.2). C-28 Sc-161 Santa Cruz Biotechnology, Inc. Rabbit Poly IgG Human, Mouse & Rat C-terminus of Human MET Peptide 15-25 amino acid long peptide mapping within the last 50 C-terminal amino acids of Human MET (Accession: NP_000236.2). * Information concerning this clone might be discrepant with information published on the internet, since the corresponding datasheet has been revised over time. 3
RkJQdWJsaXNoZXIy MTk4NDMw